Publicacions en què col·labora amb ROCÍO GARCÍA CARBONERO (25)

2017

  1. Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection

    Journal for ImmunoTherapy of Cancer, Vol. 5, Núm. 1

2015

  1. Gene expression profile predictive of response to chemotherapy in metastatic colorectal cancer

    Oncotarget, Vol. 6, Núm. 8, pp. 6151-6159

2014

  1. MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer

    BMC Cancer, Vol. 14, Núm. 1

  2. MicroRNA clusters: Dysregulation in lung adenocarcinoma and COPD

    European Respiratory Journal, Vol. 43, Núm. 6, pp. 1740-1749

  3. MicroRNA-dependent regulation of transcription in non-small cell lung cancer

    PLoS ONE, Vol. 9, Núm. 3

  4. Open-label, multicentre expansion cohort to evaluate imgatuzumab in pre-treated patients with KRAS-mutant advanced colorectal carcinoma

    European Journal of Cancer, Vol. 50, Núm. 3, pp. 496-505

2013

  1. DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: Implications for outcomes and histologic classification

    Carcinogenesis, Vol. 34, Núm. 5, pp. 1031-1038

  2. Identification of oxidative stress related proteins as biomarkers for lung cancer and chronic obstructive pulmonary disease in bronchoalveolar lavage

    International Journal of Molecular Sciences, Vol. 14, Núm. 2, pp. 3440-3455

  3. Identification of proteomic signatures associated with lung cancer and COPD

    Journal of Proteomics, Vol. 89, pp. 227-237

  4. Inhibition of HSP90 molecular chaperones: Moving into the clinic

    The Lancet Oncology, Vol. 14, Núm. 9

  5. Spinophilin loss correlates with poor patient prognosis in advanced stages of colon carcinoma

    Clinical Cancer Research, Vol. 19, Núm. 14, pp. 3925-3935

2012

  1. PDGFRα/β and VEGFR2 polymorphisms in colorectal cancer: Incidence and implications in clinical outcome

    BMC Cancer, Vol. 12

2010

  1. Expression of EGFR, HER-2/neu and KIT in germ cell tumours

    Clinical and Translational Oncology, Vol. 12, Núm. 6, pp. 443-449

2009

  1. Inhibiting PI3K as a therapeutic strategy against cancer

    Clinical and Translational Oncology, Vol. 11, Núm. 9, pp. 572-579

  2. Medical emergencies

    Textbook of Medical Oncology: Fourth Edition (CRC Press), pp. 323-350

2007

  1. Fluorouracil-based chemotherapy in patients with gastrointestinal malignancies: Influence of nutritional folate status on toxicity

    Journal of Chemotherapy, Vol. 19, Núm. 6, pp. 744-749

  2. Prognostic value of KIT expression in small cell lung cancer

    Lung Cancer, Vol. 56, Núm. 3, pp. 405-413

2006

  1. Systemic chemotherapy in the management of malignant peritoneal mesothelioma

    European Journal of Surgical Oncology, Vol. 32, Núm. 6, pp. 676-681

2002

  1. Antibiotics and growth factors in the management of fever and neutropenia in cancer patients

    Current Opinion in Hematology, Vol. 9, Núm. 3, pp. 215-221

  2. Envolving treatment of fever and neutropenia in cancer patients

    Clinical and Translational Oncology, Vol. 4, Núm. 6, pp. 297-307